Skip to main content

Eden Research to use Polish approval for Mevalone as springboard into central Europe

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive after announcing that the company's flagship bio-fungicide Mevalone has been approved for use by Polish regulators.

Smith says that the authorisation in Poland is just the beginning of a cascading process that will continue into adjacent European Union member states as well as the United Kingdom.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  252.41
-0.69 (-0.27%)
AAPL  344.99
-2.11 (-0.61%)
AMD  566.71
+6.45 (1.15%)
BAC  50.95
+0.27 (0.54%)
GOOG  320.64
+3.81 (1.20%)
META  614.37
-5.82 (-0.94%)
MSFT  527.71
-3.62 (-0.68%)
NVDA  217.29
-0.65 (-0.30%)
ORCL  130.71
+0.18 (0.14%)
TSLA  401.46
-6.00 (-1.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.